Kenya-MOU-header-620x400

Transforming the delivery of laboratory training in Kenya

Training for bleeding disorders laboratory professionals was severely impacted around the world by the COVID-19 pandemic, and Kenya was no exception. Face-to-face events became impossible, hampering the ability of laboratory personnel to get the training they needed to support people with bleeding disorders (PWBD).

Also available in: Français Español

In order to ensure that education could continue, the World Federation of Hemophilia (WFH) collaborated with the Kenya Medical Laboratory Technicians and Technologists Board (KMLTTB) and the Kenya Haemophilia Association (KHA) to develop an online learning module for laboratory professionals. The online module offers users updated educational hemophilia and bleeding disorders content, and will train an estimated 3,500 laboratory personnel this year.

KMLTTB is the national regulatory arm of laboratory services in Kenya, and is responsible for registering and licensing all laboratory professionals in the country. The organization is also responsible for accrediting laboratories, defining the core curricula for laboratory sciences (pre-service) in the country, and managing the Continuing Professional Development (CPD) program for in-service laboratory professionals.

This partnership… has enabled the laboratory board to think differently and be innovative, allowing us to deliver training online and focus on partnerships that are patient-centred.

- Abel Onyango, the Chair of Kenya Medical Laboratory Board, KMLTTB

The online system—called eLMS—is used to upload the theoretical and practical aspects of laboratory training. It’s designed to help laboratory technicians upgrade their skills so they can become laboratory technologists—a more advanced designation. The platform is managed by the Kenyan Laboratory Regulatory Authority, which provides the curriculum requirements with guidelines. Ten training institutions selected from across the country then used this guidance to develop online modules. The WFH supported the training of expert curriculum reviewers as well as “train the trainers” sessions for the technical institutions. This was done to ensure that hemophilia and bleeding disorders content was properly integrated into the curriculum.

The online format of the platform has two major benefits: firstly, it allows for training to be provided to a greater number of professionals versus in-person training. Secondly, it significantly reduces the cost of providing training by about half.

The KMLTTB will continue to collaborate with the WFH and the KHA to ensure that Kenyan laboratory professionals have a strong fundamental bleeding disorders diagnosis training in the future. To formalize this collaboration, the three parties signed a memorandum of understanding that defines their working relationship, and how they will support awareness-raising and capacity-building initiatives in the country. Currently, the first 720 laboratory professionals out of the targeted number of 3,500 are taking online training through the eLMS platform.

Special thanks go to the KMLTTB Chairman Abel Onyango; Registrar Abdulatif Ali; KHA President Kibet Shikuku, MD; and Board Member Anastasia Khasiani; whose commitment and support made this project possible.

Training of 10 technical training institution members on laboratory diagnosis
Expert review meeting
Planning meeting with KMLTTB, KHA and the WFH

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.